Literature DB >> 20821251

DNA repair pathways and their implication in cancer treatment.

Athanasios G Pallis1, Michalis V Karamouzis.   

Abstract

Many cytotoxic agents used in cancer treatment exert their effects through their ability to directly or indirectly damage DNA and thus resulting in cell death. Major types of DNA damage induced by anticancer treatment include strand breaks (double or single strand), crosslinks (inter-strand, intra-strand, DNA-protein crosslinks), and interference with nucleotide metabolism and DNA synthesis. On the other hand, cancer cells activate various DNA repair pathways and repair DNA damages induced by cytotoxic drugs. The purpose of the current review is to present the major types of DNA damage induced by cytotoxic agents, DNA repair pathways, and their role as predictive agents, as well as evaluate the future perspectives of the novel DNA repair pathways inhibitors in cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20821251     DOI: 10.1007/s10555-010-9258-8

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  12 in total

1.  Improved efficacy of acylfulvene in colon cancer cells when combined with a nuclear excision repair inhibitor.

Authors:  Paul M van Midwoud; Shana J Sturla
Journal:  Chem Res Toxicol       Date:  2013-11-05       Impact factor: 3.739

2.  Shiga toxin 1, as DNA repair inhibitor, synergistically potentiates the activity of the anticancer drug, mafosfamide, on raji cells.

Authors:  Maurizio Brigotti; Valentina Arfilli; Domenica Carnicelli; Laura Rocchi; Cinzia Calcabrini; Francesca Ricci; Pasqualepaolo Pagliaro; Pier Luigi Tazzari; Roberta R Alfieri; Pier Giorgio Petronini; Piero Sestili
Journal:  Toxins (Basel)       Date:  2013-02-21       Impact factor: 4.546

3.  5-Hydroxy-5-methylhydantoin DNA lesion, a molecular trap for DNA glycosylases.

Authors:  Yann-Vaï Le Bihan; Maria Angeles Izquierdo; Franck Coste; Pierre Aller; Françoise Culard; Tim H Gehrke; Kadija Essalhi; Thomas Carell; Bertrand Castaing
Journal:  Nucleic Acids Res       Date:  2011-04-12       Impact factor: 16.971

4.  Functional evaluation of DNA repair in human biopsies and their relation to other cellular biomarkers.

Authors:  Jana Slyskova; Sabine A S Langie; Andrew R Collins; Pavel Vodicka
Journal:  Front Genet       Date:  2014-05-23       Impact factor: 4.599

Review 5.  Estrogen signaling and the DNA damage response in hormone dependent breast cancers.

Authors:  C Elizabeth Caldon
Journal:  Front Oncol       Date:  2014-05-14       Impact factor: 6.244

Review 6.  Estrogen Receptor Signaling in Radiotherapy: From Molecular Mechanisms to Clinical Studies.

Authors:  Chao Rong; Étienne Fasolt Richard Corvin Meinert; Jochen Hess
Journal:  Int J Mol Sci       Date:  2018-03-02       Impact factor: 5.923

7.  Crosslinking reactions of 4-amino-6-oxo-2-vinylpyrimidine with guanine derivatives and structural analysis of the adducts.

Authors:  Shuhei Kusano; Shogo Ishiyama; Sik Lok Lam; Tsukasa Mashima; Masato Katahira; Kengo Miyamoto; Misako Aida; Fumi Nagatsugi
Journal:  Nucleic Acids Res       Date:  2015-08-05       Impact factor: 16.971

8.  G1 checkpoint establishment in vivo during embryonic liver development.

Authors:  Xiao Qi Wang; Kwok Kin Chan; Xiaoyan Ming; Vincent C H Lui; Randy Y C Poon; Chung Mau Lo; Chris Norbury; Ronnie T P Poon
Journal:  BMC Dev Biol       Date:  2014-05-19       Impact factor: 1.978

9.  Nuclear receptor-induced transcription is driven by spatially and timely restricted waves of ROS. The role of Akt, IKKα, and DNA damage repair enzymes.

Authors:  Bruno Perillo; Annalisa Di Santi; Gustavo Cernera; Maria Neve Ombra; Gabriella Castoria; Antimo Migliaccio
Journal:  Nucleus       Date:  2014 Sep-Oct       Impact factor: 4.197

10.  Millepachine, a potential topoisomerase II inhibitor induces apoptosis via activation of NF-κB pathway in ovarian cancer.

Authors:  Wenshuang Wu; Buyun Ma; Haoyu Ye; Taijin Wang; Xiaoyan Wang; Jianhong Yang; Yuquan Wei; Jingqiang Zhu; Lijuan Chen
Journal:  Oncotarget       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.